Fungal Species: Cunninghamella elegans

Enhanced biodegradation of fluorinated pharmaceutical by Aspergillus flavus and Cunninghamella elegans biofilms: kinetics and mechanisms

mycolabadmin

Two types of fungi, Aspergillus flavus and Cunninghamella elegans, can effectively break down pharmaceutical pollutants commonly found in wastewater, such as antidepressants and antibiotics. When grown as biofilms on foam carriers, these fungi removed over 90% of the target pharmaceuticals very quickly. The fungi accomplish this primarily through enzymatic breakdown rather than absorption, making them promising candidates for cleaning wastewater at treatment plants.

Read More »

Cunninghamella echinulata DSM1905 biofilm-based L-asparaginase production in pneumatically-driven bioreactors

mycolabadmin

Scientists tested different types of bioreactors to grow a fungus called Cunninghamella echinulata that produces L-asparaginase, an enzyme used to treat leukemia and lymphoma. They found that a special hybrid bioreactor with a mesh scaffold allowed the fungus to form a biofilm, which produced significantly more of the therapeutic enzyme than other reactor types. This discovery could improve the production of cancer-fighting medications.

Read More »

Submerged Fermentation of Rhizopus sp. for l-asparaginase Production in Lymphoma Therapy

mycolabadmin

Researchers developed a new way to produce an anti-cancer enzyme called L-asparaginase using a fungus called Rhizopus, which could offer a safer alternative to current bacterial sources. They designed and tested a special bioreactor system that allows the fungus to grow as a biofilm, significantly increasing enzyme production. The system achieved enzyme activity levels much higher than previous laboratory methods, suggesting it could be scaled up for industrial pharmaceutical production.

Read More »
Scroll to Top